New triple therapy shows promise in stomach cancer fight
NCT ID NCT04208347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy and the targeted drug apatinib improves outcomes for people with stomach or gastroesophageal junction cancer that can be surgically removed. About 580 adults will receive the treatment before and after surgery. The goal is to see if this combination leads to more complete tumor disappearance and longer survival without the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Hebei University
Baoding, China
-
Affiliated Hospital of Jiangsu University
Zhenjiang, China
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
-
Cancer Hospital of the University of Chinese Academy of Sciences
Hangzhou, China
-
Changhai Hospital
Shanghai, China
-
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
Hainan Cancer Hospital
Haikou, China
-
Hefei Cancer Hospital, Chinese Academy of Sciences
Hefei, China
-
Henan Provincial Cancer Hospital
Zhengzhou, China
-
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, China
-
Jilin Guowen Hospital
Siping, China
-
Lanzhou University Second Hospital
Lanzhou, China
-
Liaoning Cancer Hospita & Institute
Shenyang, China
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, China
-
Sichuan Cancer Hospital & Institute
Chengdu, China
-
Sichuan Provincial People's Hospital
Chengdu, China
-
Tangdu Hospital
Xi'an, China
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
-
Xiangya Hospital Central South University
Changsha, China
-
Yantai Yuhuangding Hospital
Yantai, China